Strombafort by Balkan Pharmaceuticals is a pharmaceutical-grade oral anabolic-androgenic steroid containing 10 mg of Stanozolol per tablet. Derived from dihydrotestosterone (DHT), Stanozolol possesses a unique structural modification: a pyrazole ring attached to the A-ring instead of the standard 3-keto group, alongside a 17alpha-alkylation. This chemical configuration significantly reduces its androgenic properties while amplifying anabolic activity. As an established cutting compound, athletes frequently source Winstrol to build dense, dry muscle tissue devoid of fluid retention.
A critical biological feature of Strombafort is its capacity to lower Sex Hormone-Binding Globulin (SHBG). By attenuating circulating SHBG levels, Stanozolol substantially increases the biologically active, free concentration of co-administered anabolic compounds, thereby elevating the synergistic potency of multi-compound enhancement protocols.
Due to its active elimination half-life of 8–9 hours, daily doses of Strombafort should be split into morning and evening administrations to sustain stable serum concentrations and reduce gastrointestinal irritation. Standard protocols range from 30 mg to 50 mg daily for male athletes, with cycles strictly capped at 6 to 8 weeks to manage hepatic stress.
Strombafort exhibits minimal progestogenic activity and cannot aromatize into estrogen, making it an exceptional partner for non-aromatizing injectable compounds such as Trenbolone Acetate, Masteron (Drostanolone Propionate), and Primobolan (Methenolone Enanthate). A baseline physiological dose of Testosterone Propionate is mandatory to prevent sexual dysfunction caused by endogenous suppression.
Because Stanozolol is 17alpha-alkylated, concurrent use of liver support formulations (such as TUDCA or NAC) is strongly advised. A comprehensive Post-Cycle Therapy (PCT) incorporating selective estrogen receptor modulators (SERMs) such as Clomiphene (Clomid) and Tamoxifen (Nolvadex) should be initiated 24–48 hours after the final tablet administration to restore hypothalamic-pituitary-gonadal (HPG) axis functionality.
No. Strombafort is a direct DHT derivative and does not interact with the aromatase enzyme, eliminating risks of gynecomastia and extracellular water retention.
Stanozolol exhibits a pronounced drying effect on synovial fluid. High dosages or prolonged cycles without aromatizing compounds can lead to joint discomfort. Stacking with joint support supplements or moderate testosterone dosages is advised.
Yes. As a 17-alpha-alkylated oral steroid, Strombafort exerts hepatic strain. Cycles should not exceed 6 to 8 weeks, and liver protection supplements like TUDCA or NAC should be consumed daily.
